Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Next-Generation Oncology Devices And Solutions Market?
The market encompassing advanced oncology apparatus and remedies has seen substantial recent expansion, projected to increase its value from $13.9 billion currently in 2024 to $16.41 billion next year in 2025, reflecting an aggressive 18.1% compound annual growth rate. This upward trend observed over the past period stems from several key factors, including the increasing worldwide prevalence of cancer cases, the broadening scope of cancer-related scientific investigations and patient trials, the proliferation of personalized medical approaches, an uplift in necessary hospital facilities and diagnostic capabilities, alongside greater public recognition regarding the importance of early cancer detection programs.
Anticipated swift expansion marks the future trajectory for the market encompassing next-generation medical instruments and therapeutic options for cancer, which is projected to reach a valuation of $32.32 billion by 2029, achieving an eighteen-and-a-half percent compound annual growth rate throughout this projection window; this upward momentum is fueled by several key factors, such as an increasingly elderly worldwide populace, augmented fiscal allocations directed toward fledgling oncology enterprises, escalating outlays on medical services, a heightened need for diagnostic methods that avoid or minimize surgical intervention, alongside the development of medical facilities and support systems, while prevailing currents shaping this sector involve diagnostic imagery enhanced by artificial intelligence, progress in shedding light through liquid biopsies, the rise of individually tailored medical approaches, health surveillance technology integrated into wearable items, advanced robotic systems, and instruments designed for surgical procedures requiring little intrusion.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24336&type=smp
Which Drivers Are Supporting Growth Of The Next-Generation Oncology Devices And Solutions Market?
Driven by the escalating incidence of cancer, which involves the unchecked proliferation of aberrant cells capable of systemic dissemination and subsequent functional disruption, significant advancement is anticipated within the market for cutting-edge oncology technologies and services. The primary factor contributing to this heightened cancer frequency appears to be the expanding elderly demographic, given the established correlation between age and cancer risk. These advanced oncology tools and remedies are instrumental in addressing this growing cancer burden by facilitating earlier identification, greater diagnostic accuracy, and customized therapeutic approaches. To illustrate the severity, data released in January 2024 by the American Cancer Society, a non-profit entity based in the U.S., projected that cancer would unfortunately be responsible for upwards of 611,000 deaths across the United States, meaning fatalities related to cancer would surpass 1,600 each day; consequently, the expanding rate of cancer occurrence will act as a catalyst for the expansion of the market for next-generation oncology devices and solutions.
How Is The Next-Generation Oncology Devices And Solutions Market Classified Into Different Segments?
The next-generation oncology devices and solutionsmarket covered in this report is segmented –
1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses
Subsegments:
1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma
Which Competitive Trends Are Defining The Next-Generation Oncology Devices And Solutions Market Structure?
Leading firms operating within the evolving landscape of oncology instrumentation and therapies are concentrating their efforts on pushing the boundaries of technology, particularly through the development of next-generation sequencing target enrichment methodologies, which serve to heighten the identification of infrequently occurring genetic variations, boost the precision of the sequencing process, and hasten the determination of cancer diagnoses and the initiation of therapeutic interventions.These NGS target enrichment approaches involve methods for specifically isolating and concentrating defined segments of genetic material, either DNA or RNA, prior to sequencing, thereby facilitating a more precise and productive examination of genetic mutations linked to malignancies like cancer.As an illustration, in the month of April in the year 2025, Integrated DNA Technologies (IDT), an American biotechnology entity, introduced its xGen Hybridization and Wash v3 Kit, representing a groundbreaking approach to hybridization capture engineered to expedite cancer studies by simplifying the procedures involved in next-generation sequencing workflows.This novel kit accomplishes a substantial cut in the time required for hybridization to a mere sixty minutes, permitting scientists to finalize all necessary sample preparation and advance to the sequencing stage within the span of one business day, furthermore, its capacity to discard the reliance on warmed solutions and decrease manual labor input by one-fifth positions this tool as highly amenable to automated processes and ideal for large-scale testing volumes.
Which Industry Leaders Are Driving Innovation Across The Next-Generation Oncology Devices And Solutions Market?
Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.
Download The Full Report For Exclusive Market Findings:
Which Regional Markets Are Contributing Most To The Next-Generation Oncology Devices And Solutions Industry Expansion?
North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Next-Generation Oncology Devices And Solutions Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24336&type=smp
Browse Through More Reports Similar to the Global Next-Generation Oncology Devices And Solutions Market 2025, By The Business Research Company
Oncology Biosimilar Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report
Interventional Oncology Devices Global Market Report 2025
Clinical Oncology Next Generation Sequencing Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model